MTOR and endometrial cancer: miR-101-3p (miR-101) is downregulated and mTOR and 4EBP1 are upregulated in endometrial cancer cells, promoting proliferation and invasion and suppressing apoptosis, which is reversed by the miR-101-3p mimic and/or si-mTOR [118].